MEDOVEX CORP. (NASDAQ:MDVX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
MEDOVEX CORP. (NASDAQ:MDVX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On May 17, 2017, Medovex Corp. (the “Company”) received a letter from the Listing Qualifications Department of the NASDAQ Stock Market (the “Staff”) notifying the Company that the stockholders’ equity of $1,895,299 as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 was below the minimum stockholders’ equity of $2,500,000 required for continued listing on the NASDAQ Capital Market as set forth in NASDAQ listing rule 5550(b)(1) (the “Rule”).
The Company has the right to request an appeal of this determination by May 24, 2017 or its common stock will be suspended at the opening of business on May 26, 2017. The Company intends to request an appeal of the determination within the required time period. There can be no assurance that the appeal will be granted.
MEDOVEX CORP. (NASDAQ:MDVX) Recent Trading Information
MEDOVEX CORP. (NASDAQ:MDVX) closed its last trading session down -0.02 at 1.25 with 14,687 shares trading hands.
MEDOVEX CORP. (NASDAQ:MDVX) closed its last trading session down -0.02 at 1.25 with 14,687 shares trading hands.
